Eli Lilly and Co
Amazon launches GLP-1 weight loss program, promising ‘fast, convenient’ access
Amazon GLP-1 treatment Source: Amazon Inc. Amazon is pushing deeper into the booming weight loss market, unveiling Tuesday a new program that aims to simplify access to popular GLP-1 treatments. The company said its primary care arm, Amazon One Medical, is launching a GLP-1 management program that integrates obesity treatment into routine care. The offering […]
Read More
Jim Cramer warns against chasing ‘parabolic’ stocks and says there’s opportunity in overlooked names instead
Key Points CNBC’s Jim Cramer cautioned against chasing “parabolic” tech and AI stocks, warning those trades can quickly reverse. He emphasized the importance of finding opportunities in overlooked names and the need for diversification. CNBC’s Jim Cramer said Monday he’s wary of investors piling into the market’s hottest trades, arguing that chasing “parabolic” moves often […]
Read More
Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion
The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake | Reuters Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday. Lilly will pay $3.25 billion upfront, and the remaining payments are contingent upon clinical, […]
Read More
Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era
Boxes of medication are seen on the shelves of the Keencare pharmacy, a member of the Green Light Group, on September 19, 2024 in London, England. Leon Neal | Getty Images News | Getty Images Once the go-to location for global drugmakers, Europe is now being squeezed by President Donald Trump’s aggressive trade and drug-pricing […]
Read More
Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India
The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters The market share of India’s most popular weight‑loss drugmaker, Eli Lilly, slipped in March, while rival Novo Nordisk held steady even as Indian generic drugmakers flooded the market with lower‑priced copies. Eli Lilly’s Indian market share in the GLP‑1 category of […]
Read More
As millions lose weight on GLP-1s, they’re starting to turn to retailers to refresh their wardrobes
Michelle Suter has worn mostly big and baggy clothing for years. The 63-year-old retiree who lives in a suburb of St. Louis, Missouri gave away her favorite sundresses and other form-fitting outfits, thinking she’d never be those smaller sizes again. Now, after losing about 28 pounds while taking GLP-1 drug Wegovy, she said she has […]
Read More
Inside India newsletter: Tariffs and Iran war threaten India’s $100 billion garments export goal
Hello, this is Priyanka Salve, writing to you from Singapore. Welcome to the latest edition of “Inside India“ — your one-stop destination for stories and developments from the world’s fastest growing large economy. Just as India’s textile industry was beginning to stabilize after U.S. tariffs, it received another blow. Industry leaders tell me the Iran […]
Read More